Richest Olympic cheater of all time? Lance laps the field

Armstrong raked in an estimated $218M from cycling, endorsements; 'like an atomic bomb'

Feb 20, 2013 @ 2:14 pm

Lance Armstrong is the richest cheater to be stripped of a championship or Olympic medal for using performance-enhancing drugs. It isn't even close.

A compilation of the 41-year-old American cyclist's earnings by Bloomberg News, using public documents, interviews, court testimony and marketers' comments, shows part of Armstrong's business ventures and profit centers. A record seven-time Tour de France winner from 1999 to 2005 before being stripped of the titles by the U.S. Anti-Doping Agency in August, Armstrong made more than $218 million in a career he later told Oprah Winfrey was “one big lie.” He said he used testosterone, erythropoietin and blood transfusions.

There's “no comparison” between Armstrong and other individual-sport athletes stripped of results due to doping, a group that includes sprinters Ben Johnson and Marion Jones, and cyclists Alberto Contador and Floyd Landis, according to Matt Fleming, a senior director at Marketing Arm, a Dallas-based brand consultant.

“If Ben Johnson was a firecracker, Lance Armstrong was the atomic bomb,” Fleming said in an e-mail.

Bill Stapleton, Armstrong's agent, and Mark Fabiani, Armstrong's lawyer, did not respond to e-mails seeking comment on the former cyclist's career earnings.

The duration of Armstrong's dishonesty, the millions of dollars he raised and followers he gained in the fight against cancer, and his vitriolic denials set him apart, Fleming said.

The cancer charity Armstrong founded, Livestrong, has raised more than $470 million and Armstrong himself is the organization's biggest private donor, having given almost $7 million, according to the charity.

Sponsor Deals

A major source of Armstrong's income came from product endorsements and speaking engagements, a figure estimated at $180 million by IEG, a Chicago-based sponsorship consultant. Armstrong pitched companies including Nike Inc., Luxottica Group SpA's Oakley Inc., Anheuser-Busch InBev NV's Michelob brand, Trek Bicycle Corp., and nutrition-product companies FRS and Honey Stinger. All of them dropped Armstrong following USADA's release of a 1,000-page report in October detailing his misdeeds.

“With the number of companies associated with him, the amount of years and the amount of money that was involved, all told, I just don't see anything that equates to it,” Jim Andrews, senior vice president of content strategy at IEG, said last month following Armstrong's confession.

--Bloomberg News--


What do you think?

View comments

Recommended for you

Sponsored financial news

Featured video


Top questions surrounding future of DOL fiduciary rule

Reporter Greg Iacurci and managing editor Christina Nelson discuss the biggest uncertainties springing from the Fifth Circuit Court of Appeals' decision to vacate the regulation.

Latest news & opinion

What the next market downturn means for small RIAs

Firms that have enjoyed AUM growth because of the runup in stocks may find it hard to adjust to declining revenues if the market suffers a major correction.

DOL fiduciary rule likely to live on despite appeals court loss

Future developments will hinge on whether the Labor Department continues the fight to remake the regulation its own way.

DOL fiduciary rule: Industry reacts to Fifth Circuit ruling

Groups on both sides of the fiduciary debate had plenty to say.

Fifth Circuit Court of Appeals vacates DOL fiduciary rule

In split decision, judges say agency exceeded authority.

UBS, after dumping the broker protocol, continues to see brokers come and go

The wirehouse has seen 14 individuals or teams leave and five join for a net loss of $2.4 billion in AUM


Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting It'll help us continue to serve you.

Yes, show me how to whitelist

Ad blocker detected. Please whitelist us or give premium a try.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print